Closure of Trading Window for Insiders the company from Thursday, October 01, 2026 for Unaudited Standalone & Consolidated Financial Results for thr half yera ended September 30, 2026. The Trading window will open 48 hours after declaration of said financial results

Date: 25/09/2026 Asst. General Manager, Department of Corporate Services. BSE Limited, P.J. Towers, Dalal Street, Fort, Mumbai-400001, Maharashtra, India. Respected Sir, Sub: Closure of Trading Windows for Insiders of the Company. Ref: CLINITECH LABORATORY LIMITED (CTLLAB) Scrip Code: 544220. We wish to inform the Exchange that pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended from time to time) and the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company will be closed from Thursday, October 01, 2026 for the consideration and approval of the Unaudited standalone & consolidated Financial Results of the Company for the half year ending on September 30, 2026. The Trading Window will open 48 hours after the declaration of the said Financial Results. Accordingly, all Designated Persons including Directors, Promoters & Promoter Group along with Persons Acting in Concert & their respective immediate relatives and persons having contractual & fiduciary relation with the Company including but not limited to Auditors, Accountancy Firm, Law Firms, Analysts, Consultants, etc. assisting or advising the Company, shall not involve in any transaction for dealing/trading in the Securities of the Company during the period when Trading Window is closed. The date of meeting of Board of Directors to approve the unaudited standalone & consolidated Financial Results of the Company for the half year ended on September 30, 2026 will be informed in due course. You are requested to kindly note the same. Thanking you, Yours faithfully, For Clinitech Laboratory Limited Jagdish Umakant Nayak Chairman and Managing Director DIN: 00646672